Serum amyloid A as an aid in diagnosing sepsis in equine neonates

Background Sepsis is a significant cause of morbidity and mortality in neonatal foals, especially during the first 7 days of life. Diagnosing sepsis in neonatal foals can be challenging because initial clinical signs are often ambiguous and non‐specific. Objectives To determine if the major acute phase protein serum amyloid A (SAA) as measured by a point‐of‐care SAA testing device can be used as an evidence‐based biomarker of sepsis. Study...